Canada Non-alcoholic Steatohepatitis Market (2025-2031) | Trends, Companies, Growth, Outlook, Analysis, Share, Forecast, Size & Revenue, Competitive Landscape, Industry, Value, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Canada Country Macro Economic Indicators

3.2 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, 2021 & 2031F

3.3 Canada Non-alcoholic Steatohepatitis Market - Industry Life Cycle

3.4 Canada Non-alcoholic Steatohepatitis Market - Porter's Five Forces

3.5 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F

3.7 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Disease Cause, 2021 & 2031F

3.8 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of obesity and diabetes in Canada, which are major risk factors for non-alcoholic steatohepatitis (NASH)

4.2.2 Growing awareness about the importance of early diagnosis and treatment of liver diseases

4.2.3 Advancements in diagnostic technologies and treatment options for NASH

4.3 Market Restraints

4.3.1 Limited availability of approved drugs specifically for NASH treatment

4.3.2 High costs associated with NASH diagnosis and treatment

4.3.3 Lack of standardized guidelines for the management of NASH patients

6.1 Canada Non-alcoholic Steatohepatitis Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Vitamin E and Pioglitazone, 2021- 2031F

6.1.4 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Ocaliva, 2021- 2031F

6.1.5 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Elafibranor, 2021- 2031F

6.1.6 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Selonsertib and Cenicriviroc, 2021- 2031F

6.1.7 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obeticholic Acid, 2021- 2031F

6.1.8 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Others, 2021- 2031F

6.2 Canada Non-alcoholic Steatohepatitis Market, By Sales Channel

6.2.1 Overview and Analysis

6.2.2 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.2.3 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Online Providers, 2021- 2031F

6.2.4 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.3 Canada Non-alcoholic Steatohepatitis Market, By Disease Cause

6.3.1 Overview and Analysis

6.3.2 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hypertension, 2021- 2031F

6.3.3 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Heart Disease, 2021- 2031F

6.3.4 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By High Blood Lipid, 2021- 2031F

6.3.5 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F

6.3.6 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obesity, 2021- 2031F

6.4 Canada Non-alcoholic Steatohepatitis Market, By End User

6.4.1 Overview and Analysis

6.4.2 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Canada Non-alcoholic Steatohepatitis Market Revenues & Volume, By Homecare settings, 2021- 2031F

7.1 Canada Non-alcoholic Steatohepatitis Market Export to Major Countries

7.2 Canada Non-alcoholic Steatohepatitis Market Imports from Major Countries

8.1 Percentage increase in NASH diagnosis rates in Canada

8.2 Adoption rate of advanced diagnostic technologies for NASH detection

8.3 Number of clinical trials focused on developing new treatments for NASH

9.1 Canada Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 Canada Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Sales Channel, 2021 & 2031F

9.3 Canada Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Disease Cause, 2021 & 2031F

9.4 Canada Non-alcoholic Steatohepatitis Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 Canada Non-alcoholic Steatohepatitis Market Revenue Share, By Companies, 2024

10.2 Canada Non-alcoholic Steatohepatitis Market Competitive Benchmarking, By Operating and Technical Parameters